FDA Approved: COTELLIC — Original Application (Genentech, Inc.)

View source ↗

Summary

The FDA approved COTELLIC (cobimetinib) from Genentech in an original application, marking its initial regulatory authorization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Cotellic (cobimetinib)

Snippet

ORIG AP for COTELLIC (COBIMETINIB)